Vis enkel innførsel

dc.contributor.authorWeedon-Fekjær, Harald
dc.contributor.authorBakken, Kjersti
dc.contributor.authorVatten, Lars Johan
dc.contributor.authorTretli, Steinar
dc.date.accessioned2022-05-10T07:48:38Z
dc.date.available2022-05-10T07:48:38Z
dc.date.created2012-02-14T12:53:47Z
dc.date.issued2012-01-30
dc.identifier.issn0959-8146
dc.identifier.urihttps://hdl.handle.net/11250/2994943
dc.description.abstractObjective: To quantify the separate contributions of menopausal hormone treatment and mammography screening activities on trends in incidence of invasive breast cancer between 1987 and 2008. Design: Population study using aggregated data analysed by an extended age-period-cohort model. Setting: Norway. Population: Norwegian women aged 30-90 between 1987 and 2008, including 50 102 newly diagnosed cases of invasive breast cancer. Main outcomes measures: Attributable proportions of mammography screening and hormone treatment to recent incidence of invasive breast cancer, and the remaining variation in incidence after adjustment for mammography screening and hormone treatment. Results: The incidence of invasive breast cancer in Norway increased steadily until 2002, levelled off, and then declined from 2006. All non-linear changes in incidence were explained by use of hormone treatment and mammography screening activities, with about similar contributions of each factor. In 2002, when the incidence among women aged 50-69 was highest, an estimated 23% of the cases in that age group could be attributed to mammography screening and 27% to use of hormone treatment. Conclusions: Changes in incidence trends of invasive breast cancer since the early 1990s may be fully attributed to mammography screening and hormone treatment, with about similar contributions of each factor.en_US
dc.language.isoengen_US
dc.publisherBMJen_US
dc.rightsNavngivelse-Ikkekommersiell 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/deed.no*
dc.titleUnderstanding recent trends in incidence of invasive breast cancer in Norway: age-period-cohort analysis based on registry data on mammography screening and hormone treatment useen_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2012, BMJen_US
dc.source.articlenumbere299en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode0
dc.identifier.doi10.1136/bmj.e299
dc.identifier.cristin908797
dc.source.journalBMJ. British Medical Journalen_US
dc.subject.nsiVDP::Epidemiologi medisinsk og odontologisk statistikk: 803en_US
dc.subject.nsiVDP::Epidemiology, medical and dental statistics: 803en_US
dc.identifier.citationBMJ. British Medical Journal. 2012, 344, e299.en_US
dc.source.volume344en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse-Ikkekommersiell 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse-Ikkekommersiell 4.0 Internasjonal